Search

Your search keyword '"Ipratropium adverse effects"' showing total 239 results

Search Constraints

Start Over You searched for: Descriptor "Ipratropium adverse effects" Remove constraint Descriptor: "Ipratropium adverse effects" Topic ipratropium Remove constraint Topic: ipratropium
239 results on '"Ipratropium adverse effects"'

Search Results

1. Ipratropium Bromide Nasal Spray in Non-Allergic Rhinitis: A Systematic Review and Meta-Analysis.

2. Effect of Endoscopic Posterior Nasal Neurectomy on Laryngectomy-associated Rhinorrhea: A Feasibility Study.

Catalog

Books, media, physical & digital resources

3. Nebulized Ipratropium Bromide-induced Anisocoria: Why Is Anisocoria Observed?

4. Unilateral mydriasis in a child with a ventriculoperitoneal shunt for obstructive hydrocephalus: a diagnostic dilemma.

5. Metered-dose inhaler ipratropium bromide for children with acute asthma exacerbation: A prospective, non-randomized, observational study.

6. [Unilateral mydriasis of pharmacological origin].

7. Comparison of the efficacy of aerosol inhalation between the ipratropium bromide and terbutaline on the patients with AECOPD.

8. An occupational exposure limit (OEL) approach to protect home healthcare workers exposed to common nebulized drugs.

9. Pharmacologic anisocoria due to nebulized ipratropium bromide: A diagnostic challenge.

10. Safety of Atrovent ® CFC-free inhaler: respiratory events reported from an observational cohort study in England.

11. Eye-opening Etiologies.

12. A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia.

13. Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol.

14. Unequal pupils in an asthmatic child.

15. Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility.

16. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.

19. Hypertensive heart disease and bronchodilators: Potential left ventricular outflow obstruction.

20. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.

21. Beware of nebulized bronchodilators.

22. Metered-dose inhaler ipratropium bromide in moderate acute asthma in children: A single-blinded randomised controlled trial.

23. Chronic obstructive pulmonary disease and hypertrophic obstructive cardiomyopathy: two antagonistic obstructions.

26. Anisocoria with high dose ipratropium bromide inhaler.

27. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.

28. Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease.

29. Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: a nested case-control study.

30. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.

31. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.

32. Intranasal ipratropium bromide for the common cold.

33. COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study.

34. Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease.

36. Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study.

37. Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients.

38. Intranasal ipratropium bromide for the common cold.

39. Pharmacologic unilateral mydriasis due to nebulized ipratropium bromide.

40. Inhaled anticholinergic drugs and risk of acute urinary retention.

41. Safety of ipratropium bromide.

42. Blindingly obvious--Combivent as a cause of a unilateral painless mydriasis.

43. [Anticholinergics and their cardiovascular effects--between fear and reality].

44. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.

45. Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease.

46. Cardiovascular events associated with ipratropium bromide in COPD.

47. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.

48. Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease.

49. Acute pupil asymmetry in a 6-month-old boy. Diagnosis: pharmacologic anisocoria.

50. Inhaled tiotropium bromide and risk of stroke.